18 Oct 2012: Valley View, OH – In 2012, Great Lakes NeuroTechnologies has grown its workforce by 50%, bringing sustainable, high-tech jobs to Northeast Ohio. Since 2006, the team at the biotech company has focused on developing innovative medical devices, specifically in the area of movement disorders. The successful commercialization efforts of the company have been led by their Kinesia technology [ http://www.glneurotech.com/Kinesia/ ], which provides a quantitative, telemedicine platform for assessing movement disorders such as Parkinson’s disease. Today this technology is being further developed beyond patient care, from integration in cutting-edge therapies such as deep brain stimulation, to new endpoints for clinical trials testing new pharmaceutical interventions to treat and slow disease progression.
As part of the company’s growth, Great Lakes NeuroTechnologies moved its operations to Valley View in December 2011 with 14 full-time employees. During the previous year, the company secured over $8 million in new funding from the National Institute of Health to continue the research and development of its movement disorder technologies. That funding, coupled with the company’s growing commercial sales, laid the foundation to increase employee resources. Since the beginning of 2012, the company has increased the number of employees 50%, from 14 to 21 full-time employees. The jobs have included software engineering, biomedical engineering, firmware engineering, quality management, accounting, and human resources. This growth maintains a highly skilled workforce in the region, attracting new talent to the area. In 2012, Great Lakes NeuroTechnologies has added over $580,000 in new payroll to the Northeast Ohio biotech market, with additional openings at the company still being filled.
“The past year has seen several development projects move forward as well as a growth in our commercial sales,” said Lisa Halasy, Human Resources Coordinator. “We’ve recruited talented people to keep up with Great Lakes NeuroTechnologies’ development objectives and market demand. We anticipate our growth and required resources to continue through 2013.” As new and emerging markets for the Kinesia technology continue to expand commercial opportunities, the company anticipates continued employee growth.
“We are proud to be a part of economic growth in the Cleveland area that can be driven by biomedical engineering and medical device development,” said President, Joseph Giuffrida, PhD. “Not only are we positively affecting the lives of people living with movement disorders, we are growing an exciting company and creating opportunities for talented individuals looking to make a difference.”
About Great Lakes NeuroTechnologies
Great Lakes NeuroTechnologies [ http://www.glneurotech.com/ ] is committed to pioneering innovative biomedical technologies to serve research, education, and medical communities, improving access to medical technology for diverse populations, and positively impacting quality of life for people around the world.
Amelia Earhart, 216-446-2431 – aaearhart@GLNeuroTech.com